Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHDIV.L Regulatory News (HDIV)

  • There is currently no data for HDIV

Update research from QuotedData

17 Mar 2022 12:56

RNS Number : 1635F
Henderson Diversified Income TstPLC
17 March 2022
 

Henderson Diversified Income Trust - Update research from QuotedData

 

17th March 2022

 

Ahead of the curve

 

Henderson Diversified Income (HDIV) is managed with a focus on good quality issuers of debt securities operating in growing industries. Sustainability is an important factor in any assessment of quality. On 25 February 2022, shareholders overwhelmingly approved a new investment objective and policy that seeks to better define and highlight the trust's approach to environmental, social and governance (ESG) issues.

 

Recent market jitters triggered by the war in Ukraine have left HDIV trading on a much wider discount to NAV and higher dividend yield than its long-run averages.

 

Markets were already pricing in a number of interest rate rises this year as central bankers look to choke off inflation. As we explain in this note, the managers have positioned the trust's conservative and quality-focused portfolio in anticipation of a swift end to this process. That could help trigger the next phase of outperformance by the trust, as bond yields compress and their price rises to reflect lower than expected interest rates.

 

Full research:

 

https://quoteddata.com/research/henderson-diversified-income-trust-curve-qd/ 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Henderson Diversified Income Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBVURUVUOAAR
Date   Source Headline
6th Jul 202312:00 pmRNSNet Asset Value(s)
5th Jul 202312:00 pmRNSNet Asset Value(s)
4th Jul 202312:38 pmRNSNet Asset Value(s)
3rd Jul 20231:57 pmRNSNet Asset Value(s)
30th Jun 20231:00 pmRNSNet Asset Value(s)
29th Jun 202312:47 pmRNSNet Asset Value(s)
28th Jun 202311:39 amRNSNet Asset Value(s)
27th Jun 202311:46 amRNSNet Asset Value(s)
26th Jun 20233:35 pmRNSBlock Listing Interim Review
26th Jun 20232:37 pmRNSNet Asset Value(s)
23rd Jun 20231:58 pmRNSNet Asset Value(s)
22nd Jun 20232:27 pmRNSMonthly Factsheet as at 31 May 2023
22nd Jun 20231:38 pmRNSNet Asset Value(s)
21st Jun 202312:33 pmRNSNet Asset Value(s)
20th Jun 202312:23 pmRNSNet Asset Value(s)
19th Jun 20231:37 pmRNSNet Asset Value(s)
16th Jun 20231:24 pmRNSCompliance with Market Abuse Regulation
16th Jun 202312:36 pmRNSNet Asset Value(s)
15th Jun 20231:29 pmRNSNet Asset Value(s)
14th Jun 202312:46 pmRNSNet Asset Value(s)
13th Jun 20231:21 pmRNSNet Asset Value(s)
12th Jun 20232:19 pmRNSNet Asset Value(s)
9th Jun 20232:10 pmRNSNet Asset Value(s)
8th Jun 202312:35 pmRNSNet Asset Value(s)
7th Jun 20232:27 pmRNSNet Asset Value(s)
6th Jun 202312:20 pmRNSNet Asset Value(s)
5th Jun 20232:33 pmRNSNet Asset Value(s)
2nd Jun 202312:32 pmRNSNet Asset Value(s)
1st Jun 20232:11 pmRNSNet Asset Value(s)
31st May 202312:58 pmRNSNet Asset Value(s)
30th May 20232:51 pmRNSNet Asset Value(s)
26th May 202312:34 pmRNSNet Asset Value(s)
25th May 202311:43 amRNSNet Asset Value(s)
24th May 202312:24 pmRNSMonthly Factsheet as at 30 April 2023
24th May 202312:22 pmRNSNet Asset Value(s)
23rd May 20231:02 pmRNSNet Asset Value(s)
23rd May 202310:24 amRNSDividend Declaration
22nd May 202312:20 pmRNSNet Asset Value(s)
19th May 202312:13 pmRNSNet Asset Value(s)
18th May 202312:37 pmRNSNet Asset Value(s)
17th May 202312:27 pmRNSNet Asset Value(s)
16th May 20231:13 pmRNSNet Asset Value(s)
15th May 20232:54 pmRNSNet Asset Value(s)
12th May 20231:31 pmRNSNet Asset Value(s)
11th May 202312:55 pmRNSNet Asset Value(s)
10th May 20231:16 pmRNSNet Asset Value(s)
9th May 20232:37 pmRNSNet Asset Value(s)
5th May 202312:32 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
3rd May 202312:40 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.